Jasper Therapeutics soars on Oppenheimer outperform initiation

Vertigo3d/E+ via Getty Images

  • Jasper Therapeutics (NASDAQ:JSPR) is the best performing biotech stock of the day after Oppenheimer initiated shares with an outperform rating.
  • The firm noted the company is positioned to disrupt the hematopoietic stem cell…

Click here to view the original article.